跳至主要内容
临床试验/IRCT20230803059021N1
IRCT20230803059021N1尚未招募2 期

Comparing the effectiveness of topiramate treatment with haloperidol in chronic tic disorder

Esfahan University of Medical Sciences0 个研究点目标入组 32 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 12 years(—)
性别
All

入选标准

  • parental informed consent
  • DSM-V criteria for chronic tic disorder
  • age between 6 and 12

排除标准

  • Presence of major medical disorders such as epilepsy, diabetes, heart and kidney diseases
  • mental retardation
  • Hypersensitivity to topiramate and haloperidol
  • The presence of concomitant psychiatric disorders that require drug intervention
  • History of long QT syndrome, cardiac arrhythmia, kidney stones and concurrent use of carbonic anhydrase inhibitor drugs

研究者

相似试验